Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome
- PMID: 7510915
- DOI: 10.1016/0090-4295(94)90092-2
Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome
Abstract
Objective: To evaluate the relationship between antiandrogen withdrawal and change in prostate-specific antigen (PSA) when the antiandrogen in question is other than flutamide.
Methods: Presented is a case of a patient in whom the antiandrogen casodex was discontinued after clinical progression despite combined androgen blockade.
Results: A transient decline in serum PSA was observed after casodex withdrawal.
Conclusions: The relationship between antiandrogen withdrawal and a change in PSA may be a general phenomenon, not unique to flutamide.
Comment in
-
Serum PSA decline after Casodex withdrawal.Urology. 1994 Nov;44(5):790-2. doi: 10.1016/s0090-4295(94)80234-3. Urology. 1994. PMID: 7526530 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
